PROSTATE CANCER RESEARCH — grant history
Latest income
£7.5m
Grants listed (FY2026)
17
Listed grants total
£943k
Accounts grants total
£935k
reconciliation not assessedextracted from its FY2026 accounts
Application guidance — from the funder’s own website
- How to apply: The website lists a link to 'Apply to our Seed Grants' under the 'PCR Funding for Scientists' section, but does not provide specific instructions, forms, or eligibility criteria on this page.
What this funder supports
Causes funded
Where grantees operate
- Throughout England And Wales
- Cardiff
- Northern Ireland
- Scotland
What changed: FY2025 → FY2026
| Change | Grantee | FY2025 | FY2026 |
|---|---|---|---|
| new | Dana Farber Cancer Institute | — | £213k |
| new | King’s College, London | — | £19k |
| new | University of Sheffield | — | £13k |
| new | Morehouse School of Medicine | — | £8k |
| new | University of Edinburgh | — | £7k |
| up | UCL | £35k | £68k |
| down | CARDIFF UNIVERSITY | £86k | £29k |
| not listed | University of Oxford | £105k | — |
| not listed | CRUK Beatson Institute | £96k | — |
| not listed | University of East Anglia | £41k | — |
Grants made, per its accounts filings
| Recipient | Year | Amount | Purpose |
|---|---|---|---|
| Dana Farber Cancer Institute | FY2026 | £213k | Community-targeted interventions |
| University of Cambridge | FY2026 | £139k | ProCASP |
| Newcastle University | FY2026 | £121k | Bone mets/glycans |
| University of Cambridge | FY2026 | £102k | Liquid Biopsy |
| Imperial College London | FY2026 | £101k | MmicroRNA-346 |
| UCL | FY2026 | £68k | Disparities/treatment patterns |
| Imperial College London | FY2026 | £60k | Obesity-driven PC |
| Cardiff University | FY2026 | £29k | Bone mets/Wnt |
| Imperial College London | FY2026 | £23k | EPI-EVO |
| King’s College, London | FY2026 | £19k | Racial Disparities |
| University of Sunderland | FY2026 | £17k | Racial Disparities |
| University of Sheffield | FY2026 | £13k | Bone Mets Collaboration Fund |
| University of Sheffield | FY2026 | £12k | Bone Mets Collaboration Fund |
| Morehouse School of Medicine | FY2026 | £8k | Racial Disparities |
| Imperial College London | FY2026 | £8k | Bone Mets Collaboration Fund |
| University of Edinburgh | FY2026 | £7k | Bone Mets Collaboration Fund |
| Newcastle University | FY2026 | £3k | Bone Mets Collaboration Fund |
| University of Cambridge | FY2025 | £248k | Liquid Biopsy |
| University of Cambridge | FY2025 | Unverified read£199k | PTEN and TSGs |
| Cardiff University | FY2025 | Unverified read£162k | Bone mets/Wnt |
| University of East Anglia | FY2025 | Unverified read£128k | Al/Mathematical Classification |
| University of East Anglia | FY2025 | Unverified read£122k | Disparities/PCR test |
| Imperial College London | FY2025 | Unverified read£121k | Obesity-driven PC |
| Newcastle University | FY2025 | £121k | Bone mets/glycans |
| University of Cambridge | FY2025 | £114k | ProCASP |
| Imperial College London | FY2025 | £113k | Obesity-driven PC |
| University of Oxford | FY2025 | £105k | 177Lu-PSMA |
| University of Oxford | FY2025 | £105k | 177Lu-PSMA |
| University of Sunderland | FY2025 | Unverified read£105k | Disparities/Barriers to early diagnosis |
| University of Aberdeen | FY2025 | Unverified read£98k | SoloMERS |
| CRUK Beatson Institute | FY2025 | £96k | MCL-1 |
| Newcastle University | FY2025 | Unverified read£93k | Bone mets/glycans |
| Cardiff University | FY2025 | £86k | Bone mets/Wnt |
| Newcastle University | FY2025 | Unverified read£82k | AR-V Splicing |
| University of Cambridge | FY2025 | Unverified read£82k | ProCASP |
| CRUK Beatson Institute | FY2025 | Unverified read£59k | MCL-1 |
| Newcastle University | FY2025 | £50k | Bone mets/glycans |
| University of Essex | FY2025 | Unverified read£47k | Disparities/AR risk |
| Newcastle University | FY2025 | £46k | AR-V Splicing |
| Kings College London | FY2025 | Unverified read£41k | PlexinB1 |
| University of East Anglia | FY2025 | £41k | Disparities/PCR test |
| UCL | FY2025 | Unverified read£38k | STAMPEDE |
| Imperial College London | FY2025 | £36k | MmicroRNA-346 |
| UCL | FY2025 | £35k | Disparities/treatment patterns |
| University of Sunderland | FY2025 | £21k | Disparities/Barriers to early diagnosis |
| UCL | FY2025 | £19k | Disparities/treatment patterns |
| University of East Anglia | FY2025 | £15k | Al/Mathematical Classification |
| UCL | FY2025 | £13k | STAMPEDE |
| Imperial College London | FY2025 | £1k | EPI-EVO |
| University of Cambridge | FY2024 | £199k | PTEN and TSGs |
| Cardiff University | FY2024 | £162k | Bone mets/Wnt |
| University of East Anglia | FY2024 | £128k | AI/Mathematical Classification |
| University of East Anglia | FY2024 | £122k | Disparities/PCR test |
| Imperial College London | FY2024 | £121k | Obesity-driven PC |
| University of Oxford | FY2024 | £105k | 177Lu-PSMA |
| University of Sunderland | FY2024 | £105k | Disparities/Barriers to early diagnosis |
| University of Aberdeen | FY2024 | £98k | SoloMERS |
| Newcastle University | FY2024 | £93k | Bone mets/glycans |
| Newcastle University | FY2024 | £82k | AR-V Splicing |
| University of Cambridge | FY2024 | £82k | ProCASP |
| CRUK Beatson Institute | FY2024 | £59k | MCL-1 |
| Newcastle University | FY2024 | £50k | Bone mets/glycans |
| University of Essex | FY2024 | £47k | Disparities/AR risk |
| Other Grants costs | FY2024 | £46k | |
| Kings College London | FY2024 | £41k | PlexinB1 |
| UCL | FY2024 | £38k | STAMPEDE |
| UCL | FY2024 | £35k | Disparities/treatment patterns |
| Cambridge University | FY2023 | £148k | Wnt Signalling |
| Aberdeen University | FY2023 | £144k | Bone mets/Targeting Signalling |
| King's College London | FY2023 | £137k | Immunotherapy |
| University of East Anglia | FY2023 | £134k | Machine learning models |
| Cardiff University | FY2023 | £134k | PlexinB1 |
| University of Sunderland | FY2023 | £122k | Al/Mathematical Classification |
| Oxford University | FY2023 | £98k | ProCASP |
| Cancer Research UK | FY2023 | £86k | AR-V Splicing |
| Other Grants costs | FY2023 | £70k | Targeting MCL-1 |
| UCL | FY2023 | £52k | 177Lu-PSMA |
| Newcastle University | FY2023 | £51k | Solo MERS |
| Imperial College London | FY2023 | £49k | Glycan drugs targeting bone metastasis |
| Francis Crick institute | FY2023 | £48k | PTEN and TSGs |
| Other Grants costs | FY2023 | £34k | Disparities/AR risk |
| University of Essex | FY2023 | £31k | STAMPEDE |
| Other Grants costs | FY2023 | £22k | Disparities/Barriers to early diagnosis |
| Other Grants costs | FY2023 | £12k | Obesity and Prostate Cancer |
| King’s College London | FY2022 | £137k | Immunotherapy |
| Cardiff University | FY2022 | £134k | PlexinB1 |
| Newcastle University | FY2022 | £122k | ProCASP |
| UCL | FY2022 | £113k | Machine learning models |
| Cancer Research UK | FY2022 | £112k | 177Lu-PSMA |
| Francis Crick institute | FY2022 | £86k | Targeting Wnt Signalling |
| Cambridge University | FY2022 | £80k | Wnt Signalling |
| Other Grants costs | FY2022 | £70k | Glycan drugs targeting bone metastasis |
| Aberdeen University | FY2022 | £52k | Modelling |
| Other Grants costs | FY2022 | £51k | Obesity and Prostate Cancer |
| Oxford University | FY2022 | £49k | PTEN and TSGs |
| Imperial College London | FY2022 | £44k | AR-V Splicing |
| University of East Anglia | FY2022 | £40k | SoloMERS |
| Other Grants costs | FY2022 | £34k | Targeting MCL-1 |
| Other Grants costs | FY2022 | £22k | STAMPEDE |
| Other Grants costs | FY2022 | £12k | AI/Mathematical Classification |
Write-backs & cancellations
| Recipient | Year | Amount | Purpose |
|---|---|---|---|
| University of Sunderland | FY2026 | −£8k | Disparities/Barriers to early diagnosis |